Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ciccarelli

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Drugs|June 1, 1996
Diagnosis and drug therapy of prolactinomaE Ciccarelli, F Camanni
British Journal of Industrial Medicine|December 1, 1987
Pituitary adenomas in a cosmetics factoryD Mirabelli, E Ciccarelli, F Merletti
Fertility and Sterility|April 1, 1988
Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptineE Ciccarelli, R Touzel, M Besser, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 3, 1999
The growth hormone secretagogue receptorM Korbonits, E Ciccarelli, E Ghigo, et al.
Journal of Endocrinological Investigation|October 1, 1989
Hyperprolactinemia: neuroendocrine and diagnostic aspectsF Camanni, E Ciccarelli, E Ghigo, et al.
Clinical Endocrinology|December 1, 1986
TSH response to domperidoneE Ciccarelli, E Ghigo, L Savino, et al.
Biochemical and Biophysical Research Communications|April 15, 1993
A cDNA construct allowing the expression of rat hepatic glucagon receptorsM Svoboda, E Ciccarelli, M Tastenoy, et al.
Biochemical and Biophysical Research Communications|September 15, 1993
Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptorM Svoboda, M Tastenoy, E Ciccarelli, et al.
Immunopharmacology|September 1, 1989
Natural killer activity in hyperprolactinemic patientsL Matera, E Ciccarelli, A Cesano, et al.
Clinical Endocrinology|February 1, 1994
Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemiaE Ciccarelli, S Grottoli, C Miola, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Drugs|June 1, 1996
Diagnosis and drug therapy of prolactinomaE Ciccarelli, F Camanni
British Journal of Industrial Medicine|December 1, 1987
Pituitary adenomas in a cosmetics factoryD Mirabelli, E Ciccarelli, F Merletti
Fertility and Sterility|April 1, 1988
Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptineE Ciccarelli, R Touzel, M Besser, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 3, 1999
The growth hormone secretagogue receptorM Korbonits, E Ciccarelli, E Ghigo, et al.
Journal of Endocrinological Investigation|October 1, 1989
Hyperprolactinemia: neuroendocrine and diagnostic aspectsF Camanni, E Ciccarelli, E Ghigo, et al.
Clinical Endocrinology|December 1, 1986
TSH response to domperidoneE Ciccarelli, E Ghigo, L Savino, et al.
Biochemical and Biophysical Research Communications|April 15, 1993
A cDNA construct allowing the expression of rat hepatic glucagon receptorsM Svoboda, E Ciccarelli, M Tastenoy, et al.
Biochemical and Biophysical Research Communications|September 15, 1993
Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptorM Svoboda, M Tastenoy, E Ciccarelli, et al.
Immunopharmacology|September 1, 1989
Natural killer activity in hyperprolactinemic patientsL Matera, E Ciccarelli, A Cesano, et al.
Clinical Endocrinology|February 1, 1994
Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemiaE Ciccarelli, S Grottoli, C Miola, et al.
Pageof 7